Internal Medicine Doctors in Bloomington, IN Accepting Medicare

107 Internal Medicine doctors found. Showing 101 - 107

Carter F Henrich, Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3401    Fax: 812-335-0027

Priya Vengu Ramshesh, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-676-4444    Fax: 812-676-4445

Thomas Jeffrey Worster, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1000 W 1st St, Bloomington, IN 47403 Phone: 812-332-1977    Fax: 812-332-1981

Keith F Watson, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-676-4660    Fax: 812-676-4501

Vijay Kumar Agarwal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-676-4542

Bradley W Erickson, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400    Fax: 812-332-7265

Carol Trevithick, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-676-4542

News Archive

Gene involved in regulation of serotonin predicts how much our emotions affect our relationships

What makes some people more prone to wedded bliss or sorrow than others? Researchers at UC Berkeley and Northwestern University have found a major clue in our DNA. A gene involved in the regulation of serotonin can predict how much our emotions affect our relationships, according to a new study that may be the first to link genetics, emotions, and marital satisfaction. The study was conducted at UC Berkeley.

BSD Medical receives notice of allowance for new patent

BSD Medical today announced that the company has received "official notice of allowance" for a new patent that is expected to be issued by the U.S. Patent Office.

Workshop examines Post-MDG Agenda for Global Health

Writing in the Council on Foreign Relations' (CFR) "Development Channel" blog, Yanzhong Huang, a senior fellow for global health at CFR, reports on a workshop on the post-2015 development agenda.

PharmaEngine presents PEP02 phase II studies in gastric and pancreatic cancers at ASCO 2011

PharmaEngine, Inc. announced today that two phase II studies of PEP02 (liposome irinotecan) in gastric and pancreatic cancer studies were presented at the 2011 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO) in San Francisco, CA, USA.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)